United States - English - NLM (National Library of Medicine)

larken laboratories inc. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e), dihydrocodeine bitartrate (unii: 8lxs95bsa9) (dihydrocodeine - unii:n9i9hdb855) - acetaminophen 325 mg - acetaminophen, caffeine, and dihydrocodeine bitartrate tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve acetaminophen, caffeine, and dihydrocodeine bitartrate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not been tolerated, or are not expected to be tolerated - have not provided adequate analgesia, or are not expected to provide adequate analgesia acetaminophen, caffeine, and dihydrocodeine bitartrate tablets are contraindicated for: - all children younger than 12 years of age [see warnings and precautions ] - post-operative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy [see warnings and p

United States - English - NLM (National Library of Medicine)

larken laboratories, inc. - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - ofloxacin 400 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of ofloxacin tablets and other antibacterial drugs, ofloxacin tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. ofloxacin tablets are indicated for the treatment of adults with mild to moderate infections (unless otherwise indicated) caused by susceptible strains of the designated microorganisms in the infections listed below. please see dosage and administration for specific recommendations. acute bacterial exacerbations of chronic bronchitis (abecb) due to haemophilus influenzae or streptococcus pneumoniae . because fluoroquinolones, including

United States - English - NLM (National Library of Medicine)

larken laboratories, inc. - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of ofloxacin tablets and other antibacterial drugs, ofloxacin tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. ofloxacin tablets are indicated for the treatment of adults with mild to moderate infections (unless otherwise indicated) caused by susceptible strains of the designated microorganisms in the infections listed below. please see dosage and administration for specific recommendations. acute bacterial exacerbations of chronic bronchitis (abecb) due to haemophilus influenzae or streptococcus pneumoniae . because fluoroquinolones, including

United States - English - NLM (National Library of Medicine)

larken laboratories, inc. - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline hyclate tablets are indicated for use as an adjunct to scaling and root planing to promote attachment level gain and to reduce pocket depth in patients with adult periodontitis. to reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate tablets, usp and other antibacterial drugs, doxycycline hyclate tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. this drug is contraindicated in persons who have shown hypersensitivity to doxycycline or any of the other tetracyclines.

United States - English - NLM (National Library of Medicine)

larkly, llc - titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp), zinc oxide (unii: soi2loh54z) (zinc cation - unii:13s1s8sf37) - - helps prevent sunburn - if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early aging caused by the sun do not use on damaged or borken skin stop use and ask a doctor if rash occurs

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

clark rubber franchising pty ltd - chlorine present as sodium dichloroisocyanurate; sodium tetraborate pentahydrate - granular formulation - chlorine present as sodium dichloroisocyanurate mineral-chlorine active 504.0 g/kg; sodium tetraborate pentahydrate mineral-boron other 100.0 g/kg - pool chemical - hot tub | spa | outdoor spa | spa | spa pools - algae | bacteria | chlorine stabiliser | increase longevity of chlorine

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

clark rubber franchising pty ltd - polyhexanide hydrochloride - aqueous concentrate - polyhexanide hydrochloride guanidine active 200.0 g/l - pool sanitiser - swimming pool - bacteria

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

clark rubber franchising pty ltd - copper present as copper triethanolamine complex - pool algicide - swimming pool - algae

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

clark rubber franchising pty ltd - 1,2-ethanediamine polymer with (chloromethyl) oxirane an - liquid - 1,2-ethanediamine polymer with (chloromethyl) oxirane an solution active 285.0 g/l - algicide - pond and fountain | pool - black algae | blue-green algae - phormidium spp. | water treatment/sanitiser | bluegreen algae | filamentous blue-green algae

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

clark rubber franchising pty ltd - chlorine present as calcium hypochlorite - pool chlorine - swimming pool - algae | bacteria | chlorine stabiliser | increase longevity of chlorine